Gadolinium Lawyer

Manufacturers of Gadolinium-based contrast agents issued a Dear Healthcare Professional letter to inform healthcare professionals of the addition of a BOXED WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents used in Magnetic Resonance Imaging (MRI).The text of the letter is as follows:Dear Healthcare Professional,
The manufacturers of gadolinium-based contrast […]

[Read more →]

Gadolinium (chemical symbol “Gd”) is a chemical element listed on the Periodic Table.  It was named after the Finnish chemist John Gadolin  (1760-1852) to honor his research in rare earth metals.   Gadolinium is a silvery-white rare metal which occurs naturally on Earth and is relatively stable in dry air unlike other s of that classification.  […]

[Read more →]

How will my doctor know if I am suseptible to NSF before using gadolinium in an MRI?
****************************************************************************
Unless you to your physician, he or she will not know so it’s important to communicate if you have any kidney problems before having an MRI.  To learn more, contact a Gadolinium Lawyer at Williams Kherkher.

[Read more →]

Reporting in the October issue of the American Journal of Dermatopathology, Researchers at Wake Forest University, Baptist Medical Center suggest a possible explanation for why some patients on kidney dialysis who are injected with a “contrast agent” during a magnetic resonance imaging (MRI) develop nephrogenic systemic fibrosis (NSF). a rare tightening and swelling of the […]

[Read more →]

The U.S. Food and Drug Administration (FDA) first notified health care professionals and the public about the gadolinium-related risks for NSF in June 2006 and updated the information in December.When patients undergo an MRI, gadolinium-based contrast agents are commonly used to improve the visibility of internal structures. Five gadolinium-based contrast agents have been approved for […]

[Read more →]